Promyelocytic leukemia protein (PML) nuclear bodies (NBs) are present in variable number in most human cell types and have been linked to various cellular functions, including roles as depots for DNA repair proteins. Here, we show that treatment of human cells with DNA methylating agents leads to redistribution of PML from NBs to a diffuse nuclear localization. Biochemically, this correlates with a specific reduction of PML levels in the nuclear matrix fraction without affecting total PML levels. Similar results were obtained for the other major PML NB component, the Sp100 protein, indicating that DNA methylating agents lead to a general disassembly of PML NBs. Similar to the dispersal of PML NBs in response to some viral infections, PML redistribution after DNA damage was inhibited by the proteasome inhibitor MG132. We propose that the regulated dispersal of PML NBs may facilitate the enhanced release of DNA repair proteins from NB depots in order to respond adequately to extensive DNA damage.
Promyelocytic leukemia protein (PML) nuclear bodies (NBs) are present in variable number in most human cell types and have been linked to various cellular functions, including roles as depots for DNA repair proteins. Here, we show that treatment of human cells with DNA methylating agents leads to redistribution of PML from NBs to a diffuse nuclear localization. Biochemically, this correlates with a specific reduction of PML levels in the nuclear matrix fraction without affecting total PML levels. Similar results were obtained for the other major PML NB component, the Sp100 protein, indicating that DNA methylating agents lead to a general disassembly of PML NBs. Similar to the dispersal of PML NBs in response to some viral infections, PML redistribution after DNA damage was inhibited by the proteasome inhibitor MG132. We propose that the regulated dispersal of PML NBs may facilitate the enhanced release of DNA repair proteins from NB depots in order to respond adequately to extensive DNA damage. Oncogene (2004 Oncogene ( ) 23, 307-310. doi:10.1038 Keywords: PML; Sp100; DNA alkylation; proteasome Promyelocytic leukemia protein (PML) nuclear bodies (NBs) are large (0.2-1 mm) subnuclear domains that have been linked to a wide variety of cellular functions, including apoptosis, senescence, alternative lengthening of telomeres, and DNA damage responses. A dominant fusion protein of PML with the retinoic acid receptor a caused by balanced t(15;17) chromosome translocation gives rise to acute promyelocytic leukemia (APL) and results in the disruption of PML NBs (Salomoni and Pandolfi, 2002) . The importance of the structural integrity of PML NBs is indicated by the clinical observation that their reformation in APL cells in response to retinoic acid treatment correlates with disease remission (Borden, 2002) . In addition to the PML protein as their main component, more than 50 distinct proteins have been found to be transiently or constitutively associated with PML NBs (Negorev and Maul, 2001; Borden, 2002; Salomoni and Pandolfi, 2002) . Although PML NBs are sites of some biochemical activities, for example, p53 phosphorylation by HIP kinase-2 in response to UV irradiation (Hofmann et al., 2002) , their major function may be to serve as a nuclear depot for several proteins that are recruited and released in a regulated manner (Negorev and Maul, 2001) . Such a depot function could be useful to facilitate the rapid release of stored proteins when they are required but would otherwise keep them segregated to prevent adverse cellular functions.
Several DNA damage response proteins have been reported to reside in PML NBs in the absence of DNA damage, for example, CHK2 (Yang et al., 2002) , BLM (Bischof et al., 2001) , ATR, and RPA (Barr et al., 2003) , and the MRE11-RAD50-NBS1 complex (Wu et al., 2000) . While this may relate to the depot function, a direct DNA-damage function of PML NBs has recently been implied by the finding that PML can directly associate with DNA double-strand break (DSB) repair sites in response to ionizing radiation (Carbone et al., 2002; Xu et al., 2003) . Likewise, in response to UV-Cinduced DNA damage, PML was reported to relocalize partially from PML NBs to sites of DNA repair (Seker et al., 2003) .
As a variety of distinct genotoxic agents can lead to the redistribution of DNA-damage response proteins to DNA-damage-induced nuclear foci, which have an appearance similar to PML NBs, we tested if foci formed in response to alkylating DNA damage colocalized with PML. Surprisingly, in human U2OS osteosarcoma cells, we observed that PML lost its focal appearance after treatment with the methylating agents methylmethane sulfonate (MMS) and 1-methyl-3-nitro-1-nitrosoguanidine (MNNG) (Figure 1a) . Similar results were obtained in a number of different cell lines and using different fixation methods ( Figure 1b ). In contrast, PML NBs could still be detected by immunofluorescence microscopy in response to agents that cause other forms of DNA damage, such as UV (DNA adducts and crosslinks), hydroxyurea (replication blocks and secondary DSBs), and etoposide (topoisomerase inhibition and DSBs; data not shown).
As the monoclonal antibody used for these analyses recognizes only a narrow epitope of PML, it was possible that a DNA-damage-dependent post-translational modification of this epitope had abolished the immunoreactivity with PML NBs. However, double labelling with this antibody and a polyclonal antibody directed against a much larger nonoverlapping epitope gave essentially identical results, confirming that PML disperses from NBs in response to alkylating DNA damage and assumes a more diffuse nuclear distribution (Figure 2a) . In biochemical analyses, the morphological dispersal of PML from NBs correlated with considerably reduced PML levels in the insoluble nuclear matrix fraction in response to MMS treatment (Figure 2b ). Interestingly, total nuclear PML levels did not change in response to DNA damage (Figure 2b ), consistent with a Immunofluorescence and biochemical analyses of PML dispersal after DNA damage. (a) U2OS cells were incubated with or without 0.02% MMS, fixed using methanol/acetone, and double stained using a mouse monoclonal antibody against residues 37-51 (Santa Cruz Biotechnology; sc-966) and a rabbit polyclonal antibody (Santa Cruz Biotechnology; sc-5621) directed against residues 157-394 of human PML. Secondary antibodies were goat anti-mouse IgG-Alexa Fluor 594 and goat anti-rabbit IgG-Alexa Fluor 488. Nuclei were counterstained using 4 0 ,6-diamidino-2-phenylindole (DAPI). (b) Immunoblot of PML levels in cellular fractions after DNA damage. Cell lysates were fractionated as described (De Lucia et al., 2001 ) and immunoblotted using anti-PML (sc-966) and anti-lamin B (Oncogene Research Products, clone 101-B7, Ab-1) to indicate the total protein levels subnuclear redistribution rather than degradation of solubilized PML.
To determine if PML is specifically released from NBs, or if NBs are generally disassembled in response to DNA alkylation, we performed similar analyses using an antibody against the other major PML NB component, the Sp100 protein. Importantly, in U2OS cells as well as CRL-7625 primary fibroblasts, Sp100 also lost its predominantly focal localization and assumed a more diffuse nuclear localization in response to MMS treatment (Figure 3) . The similar results for the two major PML NB components indicate that NBs do not just release their components but are essentially disassembled in response to DNA alkylation.
A similar dispersal of PML and Sp100 from NBs has previously been observed in response to viral infections, where it could be inhibited by treatment with the proteasome inhibitor MG132 (Chelbi-Alix and de The, 1999; Everett et al., 1999) . We therefore analysed the effect of MG132 on MMS-induced dispersal of PML NBs. In these experiments, MG132 led to a significant stabilization of PML NBs in response to MMS treatment (Figure 4a ). Likewise, in fractionation assays, PML remained associated with the nuclear matrix in MG132-treated DNA-damaged cells, in contrast to loss of PML from this fraction in damaged cells that were not treated with MG132 (Figure 4b) . Although MG132 by itself increased the number of PML NBs (Figure 4a ; similar to previous studies, Everett et al., 1999) as well as nuclear matrix-associated PML levels (Figure 4b ), PML NB stabilization by MG132 was not merely a secondary consequence of higher starting levels, because in the presence of MG132 neither the number of PML NBs (Figure 4a ) nor matrix-associated PML levels ( Figure 4b ) were reduced after 2 h of MMS treatment (in contrast to the minus-MG132 control). Therefore, these experiments demonstrate that PML NB dispersal by DNA alkylation is proteasome dependent. Nevertheless, the fact that MMS treatment only affected the matrix and NB associated but not total PML levels suggests that the proteasome acts in an indirect manner on PML NB integrity in response to DNA damage. This is in contrast to its role in viral infections, where PML and Sp100 are actually degraded (Chelbi-Alix and de The, 1999) . The simplest interpretation of our findings is therefore that DNA alkylation affects the proteasomedependent turnover of another factor that regulates PML NB structure, either by enhanced degradation of a PML NB stabilizing factor or reduced degradation of a PML NB solubilizing factor. While such a mechanism is currently speculative, it is important to note that it may be critical to control PML NB structure, since increases Proteasome dependence of damage-induced PML NB dispersal. U2OS cells were cultured in the presence or absence of 10 mM MG132 in DME þ 10% FBS for 2 h before the addition of 0.02% MMS for a further 2 h as indicated. Cells were analysed by immunofluorescence using the mouse anti-PML antibody (a), or fractionated for Western blot analysis (b) as described in Figure 2 in their number and size are correlated with cellular senescence and therefore seem to affect cell proliferation (Iwasa et al., 2003) adversely. PML has recently been shown to function as a CHK2 kinase substrate in the DNA-damage response (Yang et al., 2002) , and it has been speculated that this phosphorylation event may regulate the release of CHK2 and other DNA-damage response proteins from NBs (Venere et al., 2002) . However, neither overexpression of kinase-dead CHK2 nor phosphorylation site mutated PML (S117A) interfered with PML NB dispersal in response to MMS (data not shown), indicating that the results reported here are CHK2 independent.
Our data extend other recent studies that demonstrate the dynamic behavior of PML NBs in response to DNA damage, by illustrating striking differences in the specific response to diverse DNA-damage types. For example, in response to DSBs caused by ionizing radiation, PML NBs may at least partially relocalize to single-stranded DNA-containing sites of homologous recombination (Carbone et al., 2002; Barr et al., 2003; Xu et al., 2003) , whereas in response to UV-induced bulky DNA adducts and crosslinks, PML partially and transiently relocates from NBs that generally maintain their structural integrity (Seker et al., 2003) . In contrast, we show here that PML NBs completely disperse in response to alkylating DNA damage in a manner that does not only affect PML but also Sp100, the other major PML NB-associated protein. Furthermore, as the complete dispersal of PML NBs in response to DNA methylating agents also occurs in p53-negative SaOS-2 cells (Figure 1b) , it differs from the partial dispersal in response to UV damage that was reported to be p53-dependent (Seker et al., 2003) . It is unlikely that the different DNA-damage responses of PML NBs are due to use of different cell types, as we observed very similar MMS responses in a wide range of human cancer cell lines (U2OS and SaOS-2 osteosarcomas, MCF7 breast cancer cells; Figure 1b) as well as primary fibroblasts (Figure 3b ). In line with one of the proposed functions of PML NBs as nuclear depots for DNA-damage response proteins (Negorev and Maul, 2001; Venere et al., 2002; Barr et al., 2003) , the differential behavior of PML NBs could be explained by the consideration that distinct forms of DNA damage are repaired by separate mechanisms. In this sense, the repair of widespread DNA alkylations may require the rapid release of repair proteins that can only be accomplished by global PML NB dispersal.
